The percentages of IL-22-producing CD134+CD4+ T-cells were significantly decreased in SLE patients as compared to HC (10.5 ± 9.0% vs. 19.0 ± 11.8%; p = 0.01). Here, IL22 is linked to systemic lupus erythematosus.